MANAGEMENT OF ELECTRICAL INSTABILITY AFTER ICD IMPLANTATION

被引:13
作者
DIJKMAN, B [1 ]
DENDULK, K [1 ]
WELLENS, HJJ [1 ]
机构
[1] ACAD HOSP MAASTRICHT,DEPT CARDIOL,6202 AZ MAASTRICHT,NETHERLANDS
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1995年 / 18卷 / 01期
关键词
DEFIBRILLATOR; ELECTRICAL INSTABILITY; SEDATION;
D O I
10.1111/j.1540-8159.1995.tb02494.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Postoperative ventricular arrhythmias were studied in 52 patients receiving implantable cardioverter defibrillators (ICDs). A group of 9 patients was identified who experienced electrical instability (EI). The lead approach was thoracotomy in 6 and nonthoracotomy in 3 patients. In 8 of 9 patients VTs started soon after surgery. There was no evidence of ischemia, cardiac failure, electrolyte imbalance, or drug intoxication. The severity of ventricular arrhythmias varied from a considerable increase in incidence of well-tolerated VTs in 3 patients (1 incessant) to poorly tolerated frequent VTs in 6 patients (2 incessant). In 4 patients VTs led to cardiac failure. Ventricular arrhythmias during El were refractory to antiarrhythmic drugs (AAD) in 7 of 9 patients. In 3 patients VTs accelerated into fast VT or VF with antitachycardia pacing (ATP) or cardioversion. The successful management of EI was: sedation in 4 patients (3 with midazolam 2 with temazepam), ATP and AAD in 2 patients, AAD and hemodynamic support in 2 patients, spontaneous resolution in 2 patient. All patients survived the period of postoperative EI. Two patients had a relapse of EI at 2- and 9-months postimplantation, respectively, one of whom eventually died. Conclusions: EI occurred in 17% of patients after ICD implantation, had a varying degree of severity and required an individualized approach. Control of El with AAD was successful in only 2 of 9 patients. Sedation with midazolam was useful in the management of EI.
引用
收藏
页码:148 / 151
页数:4
相关论文
共 11 条
[1]  
EDEL TB, 1992, PACE, V15, P50
[2]   INITIAL EXPERIENCE WITH TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LEAD SYSTEMS - OPERATIVE MORBIDITY AND MORTALITY [J].
FRAME, R ;
BRODMAN, R ;
GROSS, J ;
HOLLINGER, I ;
FISHER, JD ;
KIM, SG ;
FERRICK, K ;
ROTH, J ;
FURMAN, S .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1993, 16 (01) :149-152
[3]  
GARTMAN DM, 1990, J THORAC CARDIOV SUR, V100, P353
[4]  
GOHN D, 1991, J AM COLL CARDIOL, V17, P86
[5]   CLINICAL-RESULTS WITH NONTHORACOTOMY ICD SYSTEMS [J].
HAUSER, RG ;
KURSCHINSKI, DT ;
MCVEIGH, K ;
THOMAS, A ;
MOWER, MM .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1993, 16 (01) :141-148
[6]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFICACY, COMPLICATIONS AND SURVIVAL IN PATIENTS WITH MALIGNANT VENTRICULAR ARRHYTHMIAS [J].
KELLY, PA ;
CANNOM, DS ;
GARAN, H ;
MIRABAL, GS ;
HARTHORNE, JW ;
HURVITZ, RJ ;
VLAHAKES, GJ ;
JACOBS, ML ;
ILVENTO, JP ;
BUCKLEY, MJ ;
RUSKIN, JN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (06) :1278-1286
[7]   EXACERBATION OF VENTRICULAR ARRHYTHMIAS DURING THE POSTOPERATIVE PERIOD AFTER IMPLANTATION OF AN AUTOMATIC DEFIBRILLATOR [J].
KIM, SG ;
FISHER, JD ;
FURMAN, S ;
GROSS, J ;
ZILO, P ;
ROTH, JA ;
FERRICK, KJ ;
BRODMAN, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (05) :1200-1206
[8]   FACTORS ASSOCIATED WITH IMPLANTATION-RELATED COMPLICATIONS [J].
MEESMANN, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (04) :649-653
[9]   OPERATIVE MORTALITY WITH IMPLANTATION OF THE AUTOMATIC CARDIOVERTER-DEFIBRILLATOR [J].
MOSTELLER, RD ;
LEHMANN, MH ;
THOMAS, AC ;
JACKSON, K .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (13) :1340-1345
[10]  
NISAM S, 1991, PACE, V2, P255